Stay updated with breaking news from Afmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Affimed (NASDAQ:AFMD – Get Rating) from a hold rating to a sell rating in a research report released on Friday morning. A number of other analysts have also issued reports on the company. Truist Financial reduced their target price on Affimed from $12.00 to $8.00 in a report on Monday, December […]
Wells Fargo & Company reissued their overweight rating on shares of Affimed (NASDAQ:AFMD – Get Rating) in a research note published on Monday morning, Benzinga reports. Wells Fargo & Company currently has a $7.00 price objective on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the stock. […]
StockNews.com lowered shares of Affimed (NASDAQ:AFMD – Get Rating) from a hold rating to a sell rating in a research note released on Friday morning. Several other research firms have also recently weighed in on AFMD. Stifel Nicolaus lowered their price target on Affimed from $2.00 to $1.00 and set a hold rating on the […]
HC Wainwright reissued their buy rating on shares of Affimed (NASDAQ:AFMD – Get Rating) in a report published on Friday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the biopharmaceutical company’s stock. AFMD has been the topic of several other research reports. SVB Leerink decreased their price objective on Affimed from […]
Affimed (NASDAQ:AFMD – Get Rating) had its price objective cut by equities researchers at Stifel Nicolaus from $2.00 to $1.00 in a research report issued to clients and investors on Friday, The Fly reports. The brokerage currently has a “hold” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ target price would suggest a potential upside […]